Transplant News and Research RSS Feed - Transplant News and Research

MedCure offers Pulsatile Anatomical Trainer service to advance medical research and training

MedCure offers Pulsatile Anatomical Trainer service to advance medical research and training

After three years in development, MedCure, Inc. has perfected a technique that mimics functioning circulatory system processes in cadaveric specimens. [More]
New version of Belmont Rapid Infuser to be introduced at ASA 2014

New version of Belmont Rapid Infuser to be introduced at ASA 2014

Belmont Instrument Corporation, the widely recognized provider of blood and fluid infusers, will be introducing the new version of The Belmont Rapid Infuser, the RI-2 at the American Society of Anesthesiologists Meeting this week in New Orleans, LA. [More]
Cyclophosphamide drug can eliminate life-threatening immune response after bone marrow transplants

Cyclophosphamide drug can eliminate life-threatening immune response after bone marrow transplants

Johns Hopkins and other cancer researchers report that a very short course of a chemotherapy drug, called cyclophosphamide, not only can prevent a life-threatening immune response in some bone marrow transplant recipients, but also can eliminate such patients' need for the usual six months of immune suppression medicines commonly prescribed to prevent severe forms of this immune response. [More]
Swedish woman gives birth to world's first womb-transplant baby

Swedish woman gives birth to world's first womb-transplant baby

In a ground-breaking research project at the University of Gothenburg, seven Swedish women have had embryos reintroduced after receiving wombs from living donors. Now the first transplanted woman has delivered a baby – a healthy and normally developed boy. The world-unique birth was acknowledged in The Lancet on 5 October. [More]
Pitt researchers awarded $1.25 million DOD grant to establish whole-eye transplantation program

Pitt researchers awarded $1.25 million DOD grant to establish whole-eye transplantation program

University of Pittsburgh School of Medicine researchers have been awarded $1.25 million from the U.S. Department of Defense to fund two projects that aim to establish the groundwork for the nation's first whole-eye transplantation program. [More]
Study finds that hospitalized patients wash their hands infrequently

Study finds that hospitalized patients wash their hands infrequently

Hospital visitors and staff are greeted with hand sanitizer dispensers in the lobby, by the elevators and outside rooms as reminders to wash their hands to stop infections, but just how clean are patients' hands? [More]
Study identifies six new genetic variants associated with habitual coffee drinking

Study identifies six new genetic variants associated with habitual coffee drinking

A new, large-scale study has identified six new genetic variants associated with habitual coffee drinking. The genome-wide meta-analysis, led by Harvard School of Public Health and Brigham and Women's Hospital researchers, helps explain why a given amount of coffee or caffeine has different effects on different people and provides a genetic basis for future research exploring the links between coffee and health. [More]
Restoration Robotics achieves major milestone: Ships 100th ARTAS Robotic System

Restoration Robotics achieves major milestone: Ships 100th ARTAS Robotic System

Restoration Robotics, Inc. announces a major milestone - the shipment of the 100th ARTAS Robotic System to Hasson & Wong Aesthetic Hair Surgery in Vancouver, BC. [More]
Bristol-Myers Squibb, MD Anderson partner to evaluate multiple immunotherapies

Bristol-Myers Squibb, MD Anderson partner to evaluate multiple immunotherapies

Bristol-Myers Squibb Company and The University of Texas MD Anderson Cancer Center today announced a novel clinical research collaboration to evaluate multiple immunotherapies, including Opdivo (nivolumab), Yervoy (ipilimumab) and three early-stage clinical immuno-oncology assets from Bristol-Myers Squibb, as potential treatment options for acute and chronic leukemia as well as other hematologic malignancies. [More]
FDA grants orphan drug designation for neuroblastoma vaccine

FDA grants orphan drug designation for neuroblastoma vaccine

The U.S. Food and Drug Administration granted orphan drug designation for a neuroblastoma vaccine from MabVax Therapeutics, providing development incentive with market exclusivity of the novel treatment for children with this deadly childhood cancer. [More]
New research on barcoding tool that tracks origin of blood cells challenges scientific dogma

New research on barcoding tool that tracks origin of blood cells challenges scientific dogma

A 7-year-project to develop a barcoding and tracking system for tissue stem cells has revealed previously unrecognized features of normal blood production: New data from Harvard Stem Cell Institute scientists at Boston Children's Hospital suggests, surprisingly, that the billions of blood cells that we produce each day are made not by blood stem cells, but rather their less pluripotent descendants, called progenitor cells. [More]
CHLA selected as first Accredited Pediatric Heart Failure Institute on the West Coast

CHLA selected as first Accredited Pediatric Heart Failure Institute on the West Coast

Children's Hospital Los Angeles is honored to be selected the first Accredited Pediatric Heart Failure Institute on the West Coast by The Healthcare Accreditation Colloquium. [More]
Children who require long-term parenteral nutrition are at risk of IAFLD

Children who require long-term parenteral nutrition are at risk of IAFLD

Children who require long-term parenteral nutrition are at risk of a potentially devastating complication called intestinal failure-associated liver disease (IAFLD). The diagnosis, prevention, and treatment of IAFLD are discussed in a new position paper in the Journal of Pediatric Gastroenterology and Nutrition, official journal of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. [More]
Retrospective study finds overuse of colonoscopies for colorectal cancer screening, surveillance

Retrospective study finds overuse of colonoscopies for colorectal cancer screening, surveillance

A retrospective study led by researchers at Brigham and Women's Hospital (BWH), has found an overuse of colonoscopies for colorectal cancer screening and surveillance. [More]
Brain cancer patients can benefit from Rapamycin drug

Brain cancer patients can benefit from Rapamycin drug

Every day, organ transplant patients around the world take a drug called rapamycin to keep their immune systems from rejecting their new kidneys and hearts. [More]
Fecal microbiota transplantation officially recommended for effective treatment of C. difficile infection

Fecal microbiota transplantation officially recommended for effective treatment of C. difficile infection

The transplantation of faecal microbiota from a healthy donor has been shown in recent clinical studies to be a safe and highly effective treatment for recurrent Clostridium difficile (C. difficile) infection and is now recommended in European treatment guidelines. [More]
Researcher calls for concerted international effort to confront organ trafficking problem

Researcher calls for concerted international effort to confront organ trafficking problem

The author of new research into organ trafficking has called for a concerted international effort to confront the problem. [More]
Daiichi Sankyo, Ambit Biosciences enter into definitive merger agreement

Daiichi Sankyo, Ambit Biosciences enter into definitive merger agreement

Daiichi Sankyo Company, Ltd. (hereinafter Daiichi Sankyo) and Ambit Biosciences, jointly announced today that they have entered into a definitive merger agreement under which Daiichi Sankyo will acquire all of the outstanding common stock of Ambit Biosciences for $15 per share in cash through a tender offer followed by a merger with a subsidiary of Daiichi Sankyo, or approximately $315 million on a fully diluted basis. [More]
CHLA achieves Accredited Pediatric Heart Failure Institute designation

CHLA achieves Accredited Pediatric Heart Failure Institute designation

Children's Hospital Los Angeles was honored by The Healthcare Colloquium as the first west coast pediatric hospital to achieve designation as an Accredited Pediatric Heart Failure Institute. [More]
Cedars-Sinai scientists test ELAD bioartificial liver support system for patients with acute liver failure

Cedars-Sinai scientists test ELAD bioartificial liver support system for patients with acute liver failure

Cedars-Sinai physicians and scientists are testing a novel, human cell based, bioartificial liver support system for patients with acute liver failure, often a fatal diagnosis. [More]